• 1
    Chailleux E, Dabouis G, Pioche D, et al. Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients. Chest. 1988; 93: 159162.
  • 2
    Antman K, Shemin R, Ryan L, et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol. 1988; 6: 147153.
  • 3
    Sridhar KS, Doria R, Raub WA Jr., Thurer RJ, Saldana M. New strategies are needed in diffuse malignant mesothelioma. Cancer. 1992; 70: 29692979.
  • 4
    Markman M, Kelsen D. Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol. 1992; 118: 547550.
  • 5
    Yates DH, Corrin B, Stidolph PN, Browne K. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax. 1997; 52: 507512.
  • 6
    Neumann V, Muller KM, Fischer M. Peritoneal mesothelioma—incidence and etiology. Pathologe. 1999; 20: 169176.
  • 7
    Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Intengen ME. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol. 1999; 70: 612.
  • 8
    Park BJ, Alexander HR, Libutti SK, et al. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP). Ann Surg Oncol. 1999; 6: 582590.
  • 9
    Sebbag G, Yan H, Shmookler BM, Chang D, Sugarbaker PH. Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg. 2000; 87: 15871593.
  • 10
    Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003; 21: 45604567.
  • 11
    Sugarbaker PH, Welch LS, Mohamed F, Glehen O. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin North Am. 2003; 12: 605621.
  • 12
    Reuter K, Raptopoulos V, Reale F, et al. Diagnosis of peritoneal mesothelioma: computed tomography, sonography, and fine-needle aspiration biopsy. AJR Am J Roentgenol. 1983; 140: 11891194.
  • 13
    Ros PR, Yuschok TJ, Buck JL, Shekitka KM, Kaude JV. Peritoneal mesothelioma. Radiologic appearances correlated with histology. Acta Radiol. 1991; 32: 355358.
  • 14
    Guest PJ, Reznek RH, Selleslag D, Geraghty R, Slevin M. Peritoneal mesothelioma: the role of computed tomography in diagnosis and follow up. Clin Radiol. 1992; 45: 7984.
  • 15
    Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg. 1995; 181: 530538.
  • 16
    Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin North Am. 2003; 12: 703727.
  • 17
    Breiman L, Fridman JH, Olsen RA, Stone CJ. Classification and regression trees. Monterey, CA: Wadsworth Publishing, 1984.
  • 18
    Sugarbaker PH. Cytoreduction including total gastrectomy for pseudomyxoma peritonei. Br J Surg. 2002; 89: 208212.
  • 19
    Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol. 1999; 43( Suppl.): S15S25.